Export

Swedish Orphan Biovitrum International AB

Financial information

The information source is the annual report of the company with business id 556329-5624

* Closing information (×1000) SEK

Fiscal year 202412 202312
Number of months: 12 12
Turnover: 24,166 Revenue Up 23,253 Revenue Down
Financial expenses: 88,329 Revenue Down 92,684 Revenue Down
Earnings before taxes: 524,836 Revenue Up -65,126 Revenue Up
Total assets: 6,329,338 Revenue Up 5,638,753 Revenue Down
Current assets: 801,343 Revenue Up 34,453 Revenue Down
Current liabilities: 7,509 Revenue Down 103,237 Revenue Up
Equity capital: 2,135,585 Revenue Up 1,396,268 Revenue Up
Share capital: 622 622
Number of employees: 0 0

Financial ratios

Solvency: 33.7% Revenue Up 24.8% Revenue Up
Turnover per employee: Infinity Infinity
Profitability: 2.171.8% Revenue Up -280.1% Revenue Up
Return on equity (ROE): 24.6% Revenue Up -4.7% Revenue Up
Current ratio: 10.671.8% Revenue Up 33.4% Revenue Down
Return on assets (ROA): 9.7% Revenue Up 0.5% Revenue Up

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202412
Number of months: 12
Turnover: 24,166
Financial expenses: 88,329
Earnings before taxes: 524,836
Total assets: 6,329,338
Current assets: 801,343
Current liabilities: 7,509
Equity capital: 2,135,585
Share capital: 622
Number of employees: 0

Financial ratios

Solvency: 33.7%
Turnover per employee: Infinity
Profitability: 2.171.8%
Return on equity (ROE): 24.6%
Current ratio: 10.671.8%
Return on assets (ROA): 9.7%